Researchers at Correlogic Systems of Bethesda, Md. and Matritech in Newton, Mass. are pursuing new methods that might displace the PSA test in a few years.
We were far along in our quest to develop a diagnostic test that can help gynecologists and other physicians determine the likelihood that a woman's ovarian mass is benign or malignant.